reference/28494216

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28494216

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Randomized Controlled Trial
issn	2374-2437
issueIdentifier	11
pageRange	e204564-
publicationName	JAMA Oncology
startingPage	e204564
bibliographicCitation	Yau T, Kang YK, Kim TY, El-Khoueiry AB, Santoro A, Sangro B, Melero I, Kudo M, Hou MM, Matilla A, Tovoli F, Knox JJ, Ruth He A, El-Rayes BF, Acosta-Rivera M, Lim HY, Neely J, Shen Y, Wisniewski T, Anderson J, Hsu C. Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial. JAMA Oncol. 2020 Nov 01;6(11):e204564. PMID: 33001135; PMCID: PMC7530824.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1709-9492 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7c7d854f36c33e7b19db6ff2a9830e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_656bd0d85cbe36d620d562022d087656 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba85fa000ec3298dff8ed1e72d66ae4c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_522e7b8242cfa9931af68805a28b3379 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_266c04b3a6f7f3ad9f20d01fa8f59a78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c605329150631cf2e47bbf2d56ad2fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4177-6417 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7137-3953 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd1faea6429d16b430a0687855dd8511 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ae8485110c720f94f2d9ec50144d94a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad2ae32524beb8b707a8a5100688c3d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc4aa08f79280cee605d0f6f19ef1313 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_269399e40e8a281b4fc875cc6e83cf93 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_969b8212a3fb167fa6681c8b538b02fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_980f149b11ab4602b8767d90e5e89622 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ec29a1576f46654b8e330837c083e3f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1cfb19576b0bf083e730fe6ad9db1419 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_621f627dd0e75d68d26dc6e351e8240a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcf0bacee5e704df380f1a163da35702 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_418c2b0f932de929535ab110f82a01fd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3f2cd76bcd147aa52c0447393dc8493 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83c9d3c24f17383fdb24d03b6aa1f711 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1122-0055 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3de64a781bf869ff9790aa5590cfaa7
date	2020-11-12^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/33001135 https://pubmed.ncbi.nlm.nih.gov/PMC7530824 https://doi.org/10.1001/jamaoncol.2020.4564
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43608 https://portal.issn.org/resource/ISSN/2374-2437
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial
discusses	http://id.nlm.nih.gov/mesh/M0446095 http://id.nlm.nih.gov/mesh/M000626138 http://id.nlm.nih.gov/mesh/M0585694
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008113Q000188 http://id.nlm.nih.gov/mesh/D008113Q000209 http://id.nlm.nih.gov/mesh/D006528Q000188 http://id.nlm.nih.gov/mesh/D006528Q000209
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000077594Q000627 http://id.nlm.nih.gov/mesh/D000077157Q000627 http://id.nlm.nih.gov/mesh/D000074324Q000627 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000971Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8911 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7989 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7996 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998

Showing number of triples: 1 to 61 of 61.